Page 241 - 2020_07-Haematologica-web

High uric acid levels and increased mortality after alloSCT
5. Martinon F, Petrilli V, Mayor A, et al. Gout- associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-241.
6. Braga TT, Forni MF, Correa-Costa M, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884.
7. Jankovic D, Ganesan J, Bscheider M, et al. The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med. 2013;210(10):1899-1910.
8. Yeh AC, Brunner AM, Spitzer TR, et al. Phase I study of urate oxidase in the reduc- tion of acute graft-versus-host disease after myeloablative allogeneic stem cell trans- plantation. Biol Blood Marrow Transplant. 2014;20(5):730-734.
9. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute
GVHD grading. Bone Marrow Transplant.
1995;15(6):825-828.
10. Lee SJ, Vogelsang G, Flowers ME. Chronic
graft-versus-host disease. Biol Blood
Marrow Transplant. 2003;9(4):215-233.
11. Kroger N, Solano C, Wolschke C, Bandini G, et al. Antilymphocyte globulin for pre- vention of chronic graft-versus-host dis-
ease. N Engl J Med. 2016;374(1):43-53.
12. Pehlivanlar-Kucuk M, Kucuk AO, et al. The association between serum uric acid level and prognosis in critically Ill patients, uric acid as a prognosis predictor. Clin Lab.
2018;64(9):1491-1500.
13. Lee HW, Choi SM, Lee J, et al. Serum uric
acid level as a prognostic marker in patients with acute respiratory distress syndrome. J Intensive Care Med. 2019;34(5):404-410.
14. Asleh R, Prasad M, Briasoulis A, et al. Uric
acid is an independent predictor of cardiac allograft vasculopathy after heart transplan- tation. J Heart Lung Transplant. 2018; 37(9):1083-1092.
15. Kim DG, Choi HY, Kim HY, et al. Association between post-transplant serum uric acid levels and kidney transplantation outcomes. PloS One. 2018; 13(12):e0209156.
16. Ostendorf BN, Blau O, Uharek L, et al. Association between low uric acid levels and acute graft-versus-host disease. Ann Hematol. 2015;94(1):139-144.
17. Haen SP, Eyb V, Mirza N, et al. Uric acid as a novel biomarker for bone-marrow func- tion and incipient hematopoietic reconsti- tution after aplasia in patients with hema- tologic malignancies. J Cancer Res Clin Oncol. 2017;143(5):759-771.
haematologica | 2020; 105(7)
1983